Grand Rounds: Individualizing Diagnosis and Therapy for IBS

Arthur Beyder, M.D., Ph.D., and Gianrico Farrugia, M.D., discuss the morbidity, pathophysiology and genetics of irritable bowel syndrome (IBS), a complex genetic disease.

Fecal microbiota transplantation (FMT)

Mayo Clinic's Robert Orenstein, D.O., and John K. DiBaise, M.D., explain and demonstrate the FMT procedures and techniques.

The increasing incidence of young-onset colorectal cancer: A call to action

Dr. Whitney Jones from the University of Kentucky in Louisville, and Jasmine Greenamyer from the Colon Cancer Alliance in Washington, D.C., discuss the article appearing in the February 2014 issue of Mayo Clinic Proceedings.

Population Screening for Barrett's Esophagus

Dr. Ganapathy A. Prasad, Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the December 2011 issue of Mayo Clinic Proceedings.

Metabolic Syndrome as a Risk Factor for Barrett's Esophagus

Noting a 2-fold increase in risk of Barrett's Esophagus, Dr. Cadman Leggett, a fellow in gastroenterology at Mayo Clinic in Rochester, MN, discusses his article appearing in the February 2013 issue of Mayo Clinic Proceedings.

Colon cancer study

An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of people with metastatic colorectal cancer, an international phase III clinical trial found.